QuantumSi Inc(QSI)
USD --+0.00%
Reward48Moderate
Risk58Medium-High
📊75%Data
Revenue down 30% YoY
QSI
+0.0 · +0.00%
USD · NASDAQ
QuantumSi Inc | Healthcare
Earnings Deterioration
Market Cap:206.09M
ℹ️
Reward Rating
48
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
58
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on QSI to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $2.68.

What is QuantumSi Inc?

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

QSI · Verdict

Moderate reward · elevated risk

QSI stands out on balance sheet and valuation, but watch the volatility signal.

Based on 88% data coverage

QSI · Verdict

What’s working & what to watch

Strengths 2

  • Balance sheet100/100

    Current ratio 11.99

  • Valuation67/100

    Above average

Watchouts 3

  • Volatility5/100

    Weak vs peers

  • Cash flow6/100

    -3021% free-cash-flow margin

  • Profitability28/100

    -3303% net margin · -52% ROE

Model-based scoring. For information only — not financial advice.

What is QuantumSi Inc?

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 206.09M.

Financial Highlights

Investment Breakdown

📈 Growth
Growth trend is developing — watch for revenue consistency over upcoming quarters.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (48)

The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap206.09M
P/E RatioN/A
Dividend YieldN/A
52 Week High3.1
52 Week Low0.887
Last AnnualDecember
IPO Date6/10/2021
IncorporatedUSA
Shares Outstanding196M
No. of Employees149
IndustryMedical Devices
ExchangeNASDAQ
Beta2.991
CurrencyUSD